Resources
Resources
In partnership with countries around the world, we have developed hundreds of resources to help strengthen the foundations of health systems. Please search our Resources to learn more about our publications, research, programmatic approaches, tools, and learnings.
Strengthening Supply Chain and Pharmaceutical Systems for Sustained Health Impact
For more than three decades, Management Sciences for Health (MSH) has partnered with countries to build high-performing supply chains that ensure reliable access to safe, effective, quality-assured medicines and people-centered pharmaceutical services. MSH takes a holistic approach that fosters country-led innovation, whole-of-society engagement and collaboration, private-sector engagement, and effective leadership and governance. This ensures both reliable, affordable access to and sustainable delivery of medical products when and where they are needed and their appropriate use to save lives and improve health.
Topical
Local Health Solutions (LHS) Factsheet
Working at the national and subnational levels, the Local Health Solutions (LHS) Activity will focus on promoting inclusive governance structures, str…
Improving Supply Chain Performance in Malagasy District Pharmaceutical Warehouses through the SPARS Approach
Integration of IPC/WASH critical conditions into quality of care and quality improvement tools and processes: Bangladesh case study
Our Experts
Amy Boldosser-Boesch
Senior Technical Director and Practice Area Lead for Health Policy, Advocacy, and Engagement and Integrated Health Care
Tamara Hafner
Senior Principal Technical Advisor, MTaPS Program, Research
Kate Henderson
Technical Director and Cluster Lead for Leadership, Management, and Governance
Waiswa Nkwanga
Senior Technical Advisor, UHC, and Coordinator of the Civil Society Engagement Mechanism for UHC2030
Kate Kikule
Senior Principal Technical Advisor, MTaPS Program, Pharmaceutical Regulatory Systems
Pedro G. Suarez
Global Technical Lead and Cluster Lead for Tuberculosis
Christian Suharlim
Principal Technical Advisor, Health Economics and Health Technology Assessment
Alaine Nyaruhirira
Principal Technical Advisor for Laboratory Systems
Allan Were
Senior Principal Technical Advisor and Cluster Lead for Vector Borne Diseases
Philippe François
Senior Technical Director, Private Sector Supply Chain Management
Justice Nonvignon
Technical Director, Primary Health Care Efficiency, Effectiveness, and Equity
Felana Rajomarison
Principal Technical Advisor and Health Financing Francophone Lead
Rebecca Levine
Technical Director and Cluster Area Lead, Women’s, Children’s, and Adolescents’ Health
Dr. Paul Ickx
Senior Principal Technical Advisor, Local Capacity Strengthening Practice Area
Key Considerations and Strategies for Strengthening COVID-19 Diagnostics Supply Chains in Low- and Middle-Income Country Settings
COVID-19 Diagnosis in Low- and Middle-income Countries: The Big New Bully Disrupting TB and HIV Diagnostic Services
Abstract COVID-19 undermines control of other infectious diseases. Diagnostics are critical in health care. This opinion paper explores approaches for…
Facilitating COVID-19 Vaccine Introduction and Distribution in Low- and Middle-income Countries
A Landscape Analysis of Laboratory Technologies for COVID-19 Response in Low- and Middle-Income Countries
COVID-19 Vaccines Pricing Policy Options for Low-Income and Middle-Income Countries
Summary The COVID-19 pandemic limits pricing policy options for vaccines. It is therefore necessary to consider what appropriate policy options govern…
Willingness to Comply with Physical Distancing Measures against COVID-19 in Four African Countries
The world is facing an unprecedented crisis related to the COVID-19 pandemic with many unknowns, which has led to much confusion and anxiety. …
Evolution of the COVID-19 pandemic over six weeks in four French-speaking countries in West Africa
The novel Coronavirus disease 2019 (COVID-19; caused by the virus SARS-CoV-2) is severely challenging health systems worldwide. In Africa, the first c…
Sharing Knowledge for Policy Action in Low- and Middle-income Countries: A Literature Review of Managed Entry Agreements
Managed entry agreements (MEAs)—a type of formal institutional arrangement between pharmaceutical companies and payers for sharing the risk with re…
A Multinational Delphi Consensus to End the COVID-19 Public Health Threat
Abstract Despite notable scientific and medical advances, broader political, socioeconomic, and behavioural factors continue to undercut the response …
Annual Report 2020: Locally Leading the Way to Fight COVID-19
Driving the Usage of Tuberculosis Diagnostic Data through Capacity Building in Low- and Middle-Income Countries
We describe a novel training programme, the tuberculosis Data Fellowship, designed to build capacity in low- and middle-income countries for tuberc…
What We Do Not Know about the Costs of Immunization Programs in Low- and Middle-Income Countries
Evidence on immunization economics is a critical input for country immunization programs, particularly in low- and middle-income countries (LMICs) wit…